Modulation of Wnt-specific colon cancer cell kill by butyrate and lithium

Oncology Research

Volumn 14, Issue 9, 2004, Pages 427-438

  Bordonaro, Michael ^a,b   Lazarova, Darina L ^a   Carbone, Rocco ^a   Sartorelli, Alan C ^a  

^a YALE CANCER CENTER   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Butyrate; Colon cancer; Gene therapy; Lithium; Tcf; Wnt

Indexed keywords

BUTYRIC ACID; DIPHTHERIA TOXIN; FAS ASSOCIATED DEATH DOMAIN PROTEIN; GREEN FLUORESCENT PROTEIN; LITHIUM; WNT PROTEIN;

ARTICLE; CANCER INHIBITION; CELL SPECIFICITY; COLON CANCER; COLORECTAL CANCER; CONTROLLED STUDY; CYTOMEGALOVIRUS; EXPRESSION VECTOR; GENE CONSTRUCT; GENE EXPRESSION REGULATION; GENE TARGETING; GENE THERAPY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROMOTER REGION; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION;

EID: 4644339192     PISSN: 09650407     EISSN: None     Source Type: Journal    
DOI: 10.3727/0965040041791428     Document Type: Article

References (34)

1. Su, L.-K.; Vogelstein, B.; Kinzler, K. Association of the APC gene product with β-catenin. Science 262:1731-1734; 1993.
2. Munimetsu, S.; Albert, I.; Souza, B.; Rubinfeld, B.; Polakis, P. Regulation of intracellular beta-catenin levels by the adenomatous polyposis coli (APC) tumor-suppresser protein. Proc. Natl. Acad. Sci. USA 92:3046-3050; 1995.
3. Molenaar, M.; van de Wetering, M.; Oosterwegel, M.; Peterson-Maduro, J.; Godsave, S.; Korinek, V.; Roose, J.; Destree, O.; Clevers, H. XTcf-3 transcription factor mediates beta-catenin-induced axis formation in Xenopus embryos. Cell 86:391-399; 1996.
4. Behrens, J.; Von Kries, J. P.; Kuhl, M.; Bruhn, L.; Wedlich, D.; Grosschedl, R.; Birchmeier, W. Functional interaction of β-catenin with the transcriptional factor EF-1, Nature 382:638-642; 1996.
5. Korinek, V.; Barker, N.; Morin, P. J.; van Wichen, D.; de Weger, R.; Kinzler, K. W.; Vogelstein, B.; Clevers, H. Constitutive transcriptional activation by a beta-catenin-Tcf complex in APC -/- colon carcinoma. Science 275: 1784-1787; 1997.
6. Morin, P. J.; Sparks, A. B.; Korinek, V.; Barker, N.; Clevers, H.; Vogelstein, B.; Kinzler, K. W. Activation of beta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC. Science 275:1787-1790; 1997.
7. Korinek, V.; Barker, N.; Moerer P.; van Donselaar E.; Huls, G.; Peters, P. J.; Clevers, H. Depletion of epithelial stem-cell compartments in the small intestine of mice lacking Tcf-4. Nat. Genet. 19:379-383; 1998.
8. Kinzler, K. W.; Vogelstein, B. Lessons from hereditary colorectal cancer. Cell 87:159-170; 1996.
9. Roose, J.; Clevers, H. Tcf transcription factors: Molecular switches in carcinogenesis. Biochim. Biophys. Acta 87456:M23-27; 1999.
10. Miyaki, M.; Iijima, T.; Kimura, J.; Yasuno, M.; Mori, T.; Hayashi, Y.; Koike, M.; Shitara, N.; Iwama, T.; Kuroki, T. Frequent mutations of β-catenin and APC genes in primary colorectal tumors from patients with hereditary nonpolyposis colorectal cancer. Cancer Res. 59:4506-4509; 1999.
11. Westphal, E. M.; von Melchner, H. Gene therapy approaches for the selective killing of cancer cells. Curr. Pharm. Des. 8:1683-1694; 2002.
12. Harrison, G. S.; Maxwell, F.; Long, C. J.; Rosen, C. A.; Glode, L. M.; Maxwell, I. H. Activation of a diphtheria toxin A gene by expression of human immunodeficiency virus-1 Tat and Rex proteins in transfected cells. Hum. Gene Ther. 2:53-60; 1991.
13. Kondo, S.; Ishizaka, Y.; Okada, T.; Kondo, Y.; Hitomi, M.; Tanaka, Y.; Haqqi, T.; Barnett, G. H.; Barna, B. P. FADD gene therapy for malignant gliomas in vitro and in vivo. Hum. Gene Ther. 20:1599-1608; 1998.
14. Cao, G. W.; Qi, Z. T.; Pan, X.; Zhang, X. Q.; Miao, X. H.; Feng, Y.; Lu, X. H.; Kuriyama, S.; Du, P. Gene therapy for human colorectal carcinoma using CEA promoter controlled bacterial ADP-ribosylating toxin genes human CEA:PEA & DTA gene transfer. World J. Gastoenterol. 4:388-391; 1998.
15. Qiao, J.; Doubrovin, M.; Sauter, B. V.; Huang, Y.; Guo, Z. S.; Balatoni, J.; Akhurst, T.; Blasberg, R. G.; Tjuvajev, J. G.; Chen, S. H.; Woo, S. L. Tumor-specific transcriptional targeting of suicide gene therapy. Gene Ther. 9: 168-175; 2002.
16. Chen, R. H.; McCormick, F. Selective targeting to the hyperactive beta-catenin/T-cell factor pathway in colon cancer cells. Cancer Res. 61:4445-4449; 2001.
17. Richards, C. A.; Austin, E. A.; Huber, B. E. Transcriptional regulatory sequences of carcinoembryonic antigen: Identification and use with cytosine deaminase for tumor-specific gene therapy. Hum. Gene Ther. 6:881-893; 1995.
18. Ge, K.; Jiang, Q.; Xu, D. H.; Zheng, Z. C.; Liu, X. Y. Experimental treatment for human colorectal carcinoma by tissue type specific expression of herpes simplex virus thymidine kinase gene. Shi Yan Sheng Wu Xue Bao 31: 259-264; 1998.
19. Kwong, K. Y.; Zou, Y.; Day, C.-P.; Hung, M. C. The suppression of colon cancer cell growth in nude mice by targeting β-catenin/TCF pathway. Oncogene 21:8340-8346; 2002.
20. Nyati, M. K.; Sreekumar, A.; Li, S.; Zhang, M.; Rynkiwicz, S. D.; Chinnaiyan, A. M.; Rehemtulla, A.; Lawrence, T. S. High and selective expression of yeast cytosine deaminase under a carcinoembryonic antigen promoter-enhancer. Cancer Res. 62:2337-2342; 2002.
21. Fuerer, C.; Iggo R. Adenoviruses with Tcf binding sites in multiple early promoters show enhanced selectivity for tumour cells with constitutive activation of the wnt signaling pathway. Gene Ther. 9:270-281; 2002.
22. Malerba, M.; Daeffler, L.; Rommelaere, J.; Iggo, R. D. Replicating parvoviruses that target colon cancer cells. J. Virol. 77:6638-6691; 2002.
23. Cummings, J. H.; Pomare, E. W.; Branch, W. J.; Naylor, C. P.; Macfarlane, G. T. Short chain fatty acids in human large intestine, portal, hepatic and venous blood. Gut 28: 1221-1227; 1987.
24. Bordonaro, M.; Mariadason, J. M.; Aslam, F.; Heerdt, B. G.; Augenlicht, L. H. Butyrate-induced apoptotic cascade in colonic carcinoma cells: Modulation of the beta-catenin-Tcf pathway and concordance with effects of sulindac and trichostatin A but not curcumin. Cell Growth Differ. 10: 713-720; 1999.
25. Bordonaro, M.; Lazarova, D. L.; Augenlicht, L. H.; Sartorelli, A. C. Cell type- and promoter-dependent modulation of Wnt signaling pathway by sodium butyrate. Int. J. Cancer 97:42-51; 2002.
26. Hedgepeth, C. M.; Conrad, L. J.; Zhang, J.; Huang, H. C.; Lee, V. M.; Kelin, P. S. Activation of the Wnt signaling pathway: A molecular mechanism for lithium action. Dev. Biol. 85:82-91; 1997.
27. Staal, F. J.; Noort van, M.; Strous, G. J.; Clevers, H. C. Wnt signals are transmitted through N-terminally dephosphorylated beta-catenin. EMBO Rep. 3:65-68; 2002.
28. Chinnaiyan, A. M.; O'Rourke, K.; Tewari, M.; Dixit, V. M. FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis. Cell 81:505-512; 1995.
29. Efstathiou, J. A.; Liu, D.; Wheeler, J. M.; Kim, H. C.; Beck, N. E.; Ilyas, M.; Karayiannakis, A. J.; Mortensen, N. J.; Kmiot, W.; Playford, R. J.; Pignatelli, M.; Bodmer, W. G. Mutated epithelial cadherin is associated with increased tumorigenicity and loss of responsiveness to the motogenic trefoil factor 2 in colon carcinoma cells. Proc. Natl. Acad. Sci. USA 96:2316-2321; 1999.
30. da Costa, L. T.; He, T. C.; Yu, J.; Sparks, A. B.; Morin, P. J.; Polyak, K.; Laken, S.; Vogelstein, B.; Kinzler, K. W. CDX2 is mutated in a colorectal cancer with normal APC/beta-catenin signaling. Oncogene 18:5010-5014; 1999.
31. Stewart, D. B.; Nelson, W. J. Identification of four distinct pools of catenins in mammalian cells and transformation-dependent changes in catenin distributions among these pools. J. Biol. Chem. 272:29652-29662; 1997.
32. Crawford, H. C.; Fingleton, B. M.; Rudolph-Owen, L. A.; Goss, K. J.; Rubinfeld, B.; Polakis, P.; Matrisian, L. M. The metalloproteinase matrilysin is a target of beta-catenin transactivation in intestinal tumors. Oncogene 18: 2883-2891; 1999.
33. Schroder, C.; Eckert, K.; Maurer, H. R. Tributyrin induces growth inhibitory and differentiating effects on HT-19 colon cancer cells in vitro. Int. J. Oncol. 13:1335-1340, 1998.
34. Harig, J. M.; Soergel, K. H.; Komorowski, R. A.; Wood, C. M. Treatment of diversion colitis with short-chain fatty acid irrigation. N. Engl. J. Med. 320:23-28; 1989.